Nidal M. Almasri

1.3k total citations
41 papers, 947 citations indexed

About

Nidal M. Almasri is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Nidal M. Almasri has authored 41 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Nidal M. Almasri's work include Lymphoma Diagnosis and Treatment (16 papers), Viral-associated cancers and disorders (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Nidal M. Almasri is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Viral-associated cancers and disorders (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Nidal M. Almasri collaborates with scholars based in Jordan, United States and Saudi Arabia. Nidal M. Almasri's co-authors include Raul C. Braylan, Jose Iturraspe, Taiseer Hussain Al-Khateeb, Mohammad Al Hamad, Eric T. Everett, Ricardo E. Duque, Nancy P. Mendenhall, Firas Alzoubi, Abed Al‐Hadi Hamasha and Mousa A. Al‐Abbadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Scientific Reports.

In The Last Decade

Nidal M. Almasri

37 papers receiving 905 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nidal M. Almasri Jordan 16 581 439 201 169 151 41 947
Cathy Burton United Kingdom 16 479 0.8× 304 0.7× 182 0.9× 209 1.2× 58 0.4× 38 848
Francesco Bacci Italy 15 610 1.0× 408 0.9× 131 0.7× 71 0.4× 117 0.8× 47 934
H K Müller‐Hermelink Germany 20 693 1.2× 496 1.1× 228 1.1× 277 1.6× 196 1.3× 30 1.2k
Geraldine Pinkus United States 15 541 0.9× 390 0.9× 279 1.4× 99 0.6× 125 0.8× 25 1.1k
S Pileri Italy 17 449 0.8× 337 0.8× 212 1.1× 119 0.7× 179 1.2× 36 1.3k
Jens Krugmann Austria 18 432 0.7× 402 0.9× 229 1.1× 101 0.6× 99 0.7× 41 857
Mark A. Arnesen United States 11 573 1.0× 445 1.0× 397 2.0× 121 0.7× 172 1.1× 12 1.2k
Elizabeth Hyjek United States 19 339 0.6× 452 1.0× 110 0.5× 159 0.9× 154 1.0× 26 1.2k
José R. Valbuena United States 18 357 0.6× 204 0.5× 182 0.9× 180 1.1× 156 1.0× 41 809
Jun‐ichi Tamaru Japan 21 862 1.5× 771 1.8× 267 1.3× 290 1.7× 227 1.5× 108 1.5k

Countries citing papers authored by Nidal M. Almasri

Since Specialization
Citations

This map shows the geographic impact of Nidal M. Almasri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nidal M. Almasri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nidal M. Almasri more than expected).

Fields of papers citing papers by Nidal M. Almasri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nidal M. Almasri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nidal M. Almasri. The network helps show where Nidal M. Almasri may publish in the future.

Co-authorship network of co-authors of Nidal M. Almasri

This figure shows the co-authorship network connecting the top 25 collaborators of Nidal M. Almasri. A scholar is included among the top collaborators of Nidal M. Almasri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nidal M. Almasri. Nidal M. Almasri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Ibraheem, Akram, et al.. (2025). The Role of [18F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma. Cancers. 17(2). 231–231. 1 indexed citations
2.
Abdlkadir, Ahmed Saad, et al.. (2024). 18F-FDG PET/CT Unveils Coexistent Myelomatous Hepatosplenic and Thyroid Cartilage Involvement. Clinical Nuclear Medicine. 49(9). 897–898.
3.
Al‐Ibraheem, Akram, et al.. (2023). Classical Hodgkin Lymphoma on the Background of Castleman Disease: A Case Report. Cureus. 15(9). e44930–e44930.
4.
Almasri, Nidal M., et al.. (2023). Breast cancer with scalp metastases: a case report. Journal of Medical Case Reports. 17(1). 203–203. 3 indexed citations
5.
Almasri, Nidal M., et al.. (2022). Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma. Frontiers in Pediatrics. 10. 1059527–1059527. 2 indexed citations
6.
Chaar, Mohamad K. Abou, et al.. (2020). Metastatic non-functional paraganglioma to the lung. Journal of Cardiothoracic Surgery. 15(1). 82–82. 1 indexed citations
7.
Almasri, Nidal M., et al.. (2015). MRI and Ultrasonography for assessing multifocal disease and tumor size in breast cancer: Comparison with histopathological results.. PubMed. 1(17). 65–72. 7 indexed citations
9.
Al-Khateeb, Taiseer Hussain, Nidal M. Almasri, & Firas Alzoubi. (2008). Cutaneous Cysts of the Head and Neck. Journal of Oral and Maxillofacial Surgery. 67(1). 52–57. 65 indexed citations
10.
Al‐Abbadi, Mousa A., Nidal M. Almasri, Samer Z. Al‐Quran, & Edward J. Wilkinson. (2007). Cytokeratin and Epithelial Membrane Antigen Expression in Angiosarcomas: An Immunohistochemical Study of 33 Cases. Archives of Pathology & Laboratory Medicine. 131(2). 288–292. 32 indexed citations
11.
Almasri, Nidal M., et al.. (2004). Non-Hodgkin lymphoma in Jordan. Types and patterns of 111 cases classified according to the WHO classification of hematological malignancies.. PubMed. 25(5). 609–14. 20 indexed citations
12.
Almasri, Nidal M.. (2004). Hodgkins lymphoma in North Jordan. Does it have a different pattern?. PubMed. 25(12). 1917–21. 7 indexed citations
14.
Almasri, Nidal M. & Hasan S. Khalidi. (2004). Epstein-Barr virus expression in Hodgkin's disease in Jordan.. PubMed. 25(6). 770–5. 9 indexed citations
15.
Ahrens, Kim, Raul C. Braylan, Nidal M. Almasri, Robin M. Foss, & Lisa M. Rimsza. (2002). IgH PCR of Zinc Formalin-Fixed, Paraffin-Embedded Non-Lymphomatous Gastric Samples Produces Artifactual “Clonal” Bands Not Observed in Paired Tissues Unexposed to Zinc Formalin. Journal of Molecular Diagnostics. 4(3). 159–163. 5 indexed citations
16.
Mergo, Patricia J., Marta Voytovich, Dani S. Zander, et al.. (1999). Pulmonary mucosa-associated lymphoid tissue lymphoma: CT and pathologic findings.. American Journal of Roentgenology. 172(5). 1321–1326. 38 indexed citations
17.
Mendenhall, Nancy P., et al.. (1999). Non-Hodgkin's lymphoma of the head and neck: A 30-year experience at the university of Florida. Head & Neck. 21(3). 247–254. 45 indexed citations
18.
Al-Sheyyab, Mahmoud, et al.. (1996). Sickle cell anaemia in Jordan and its clinical patterns. Annals of Tropical Paediatrics. 16(3). 249–253. 5 indexed citations
19.
Al-Jaberi, Tareq M., et al.. (1994). Adult rhabdomyosarcoma of the gall bladder: case report and review of published works.. Gut. 35(6). 854–856. 8 indexed citations
20.
Almasri, Nidal M., Ricardo E. Duque, Jose Iturraspe, Eric T. Everett, & Raul C. Braylan. (1992). Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. American Journal of Hematology. 40(4). 259–263. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026